Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cuprofen Maximum Strength 400mg tablets
1001010J0BMACAE
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | 59 |
|
Cuprofen 200mg tablets
1001010J0BMAAAD
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen for Children 100mg/5ml oral suspension
1001010J0BMADBH
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen PLUS tablets
1001010J0BMAEAY
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.